PEG That Reaction: A Case Series of Allergy to Polyethylene Glycol

Fionnuala Cox,Khairin Khalib,Niall Conlon

DOI: https://doi.org/10.1002/jcph.1824

2021-02-28

The Journal of Clinical Pharmacology

Abstract:<p>Polyethylene glycol (PEG), also known as Macrogol, is an excipient in numerous medications, healthcare products, cosmetics and foods. It acts as an inert bulking, or stabilising, agent. Despite its ubiquity, including in two of the newly launched vaccines against SARS CoV2, awareness of PEG allergy remains low. We present six cases of acute hypersensitivity to PEG. Accurate diagnoses in these cases posed a challenge, and whilst the triggering agents differed, PEG was demonstrated as the common culprit. All cases were female with a mean age of 36.4 years. Four patients were originally suspected to have non‐steroid anti‐inflammatory drug (NSAID) allergy, and two had a history of chronic spontaneous urticaria and angioedema (CSUA). Biphasic allergic reactions featured prominently in this case series. Diagnosis relies on a high index of suspicion leading to a focussed clinical history, supported by skin tests with PEG solutions to demonstrate sensitisation. This case series highlights important clinical features of this rare, potentially serious and increasingly recognised excipient allergy.</p><p>This article is protected by copyright. All rights reserved</p>